Stock values increasing and decreasing in value
Markets

One-Time Costs Weigh on Merck’s Q2 Results (MRK)

Drugmaker Merck & Co., Inc. ( MRK

) said Friday that its second quarter profit plunged 52% from last year, hurt by several one-time items, but adjusted profit beat analyst expectations.

The Kenilworth, NJ-based compared reported second quarter net income of $752.4 million, or 24 cents per share, compared with $1.56 billion, or 74 cents per share, in the year-ago period.

Excluding multiple one-time items, however, adjusted profit was a much-higher 86 cents per share, and revenue nearly doubled from last year, to $11.35 billion.

On average, Wall Street analysts expected a smaller adjusted profit of 83 cents per share, albeit on slightly higher revenue of $11.45 billion.

Looking ahead, the company forecast full-year earnings of 82 cents to $1.16 per share, or $3.29 to $3.39 on an adjusted basis. Analysts currently expect a full-year adjusted profit of $3.37 per share.

Merck shares fell 71 cents, or -2%, in premarket trading Friday.

The Bottom Line

Shares of MRK have a 4.34% dividend yield, based on last night's closing stock price of $35.06. The stock has technical support in the $32-$33 price area. If the shares can firm up, we see overhead resistance around the $38 price level. We would remain on the sidelines for now.

Merck & Co., Inc. ( MRK ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRK

Other Topics

Stocks

Latest Markets Videos